| Trial ID: | L6574 |
| Source ID: | NCT01244971
|
| Associated Drug: |
Acarbose
|
| Title: |
Exercise and Acarbose in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Acarbose|BEHAVIORAL: Exercise|OTHER: Exercise + Acarbose
|
| Outcome Measures: |
Primary: Glycemic control, Glycated A1c, 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Karolinska Institutet | Collaborators: The Swedish Research Council|Bayer
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
62
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-01
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2010-11-22
|
| Locations: |
Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital, Stockholm, 17176, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT01244971
|
